Generic lenacapavir HIV prevention shot wins US FDA approval
The FDA has approved a generic version of lenacapavir, a twice-yearly HIV prevention injection, potentially clearing a regulatory hurdle for lower-cost supplies in low- and middle-income countries.
Read the full story at IOL (opens in a new tab)
This summary is the opening of the publisher's own description, trimmed. We have not added to it. The full report, and the credit for it, belong to IOL. See something wrong? Tell us.
